Codes / ICD10CM / E72.00

E72.00 Disorders of amino-acid transport, unspecified

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Disorders of amino-acid transport, unspecified (ICD-10 Code: E72.00)

Summary

Disorders of amino-acid transport, unspecified, refer to conditions where the body’s ability to transport amino acids across cell membranes is impaired, though the specific type of transport defect is not further defined. These disorders can disrupt protein synthesis, metabolic pathways, and cellular function, potentially leading to systemic effects depending on the affected amino acids and tissues involved.

Causes

These disorders are typically caused by genetic mutations affecting transport proteins or regulatory mechanisms involved in amino-acid movement. Inherited in an autosomal recessive pattern, they require two mutated gene copies to manifest. The mutations disrupt normal transport processes, leading to abnormal amino-acid accumulation or deficiency in cells or tissues.

Risk Factors

  • Family history of amino-acid transport disorders.
  • Consanguinity (parents who are close relatives) increasing recessive inheritance risk.
  • Ethnic or geographic prevalence of specific genetic variants in certain populations.

Symptoms

  • Neurological symptoms such as developmental delays, seizures, or intellectual disability.
  • Gastrointestinal issues like vomiting, poor feeding, or failure to thrive.
  • Hepatic or renal dysfunction in severe cases.
  • Metabolic imbalances due to disrupted amino-acid levels.

Diagnosis

Diagnosis involves clinical evaluation of symptoms, biochemical testing to assess amino-acid levels in blood or urine, and genetic testing to identify mutations. Newborn screening may detect some cases, though specificity depends on the disorder. Imaging or organ function tests may be used to assess systemic involvement.

Treatment Options

Treatment focuses on managing symptoms and preventing complications, such as dietary modifications to limit affected amino acids, supplements to address deficiencies, and medications to support metabolic pathways. In severe cases, organ-specific therapies (e.g., renal or hepatic support) may be necessary.

Prognosis and Follow-Up

Prognosis varies based on the severity and specific transport defect. Early diagnosis and intervention can improve outcomes, but long-term management is often required. Regular follow-up with metabolic specialists, monitoring of organ function, and adherence to dietary or therapeutic plans are essential.

Complications

  • Neurological impairment (e.g., developmental delays, seizures).
  • Organ damage (e.g., liver or kidney dysfunction).
  • Metabolic crises due to amino-acid imbalances.
  • Growth retardation or failure to thrive.

Lifestyle & Prevention

  • Adherence to prescribed dietary restrictions or supplements.
  • Avoiding triggers that may exacerbate symptoms (e.g., certain foods or medications).
  • Regular monitoring of metabolic status and organ function.
  • Genetic counseling for families with a history of these disorders.

When to Seek Professional Help

Seek immediate medical attention for symptoms like severe vomiting, lethargy, seizures, or signs of metabolic crisis. Routine follow-up is necessary for ongoing management, especially if symptoms worsen or new issues arise.

Tips for Medical Coders

Document the clinical context and diagnostic findings to support the unspecified nature of the disorder. Ensure coding aligns with the absence of more specific transport defect details. Include any relevant lab results or genetic testing to justify the unspecified classification.

Medical Policies and Guidelines

Related policies from health plans

Book a walkthrough

E72.00 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.